An abundance of microRNA-21 predicts lower survival in people with hard-to-treat 'triple-negative' breast cancer. An innovative compound targets the oncogenic sequence and removes it, killing the cancer cells and stopping their spread in a mouse model, while leaving healthy cells untouched.
from Breast Cancer News -- ScienceDaily https://ift.tt/3aIT3Nc
0 comments:
Post a Comment